With the number of COVID-19 cases rising again in Switzerland, it is worth restating the measures ELZA is taking to combat COVID-19 and protect everyone in the clinic – patients and staff alike – from the threat this virus poses.
ELZA at the WOC 2020 Virtual Meeting: Dion Paridaens MD, PhD, Chief Executive of the European Society of Ophthalmic Plastic & Reconstructive Surgery (ESOPRS) and oculoplastic & orbital surgeon at the ELZA Institute, Zurich took part in WOC 2020 Virtual Meeting in his role as a Subspecialty Coordinator for Orbital, Oculoplastic, and Lacrimal Diseases.
Corneal Cross-Linking strengthens and sterilizes the cornea.. Here is a simple proposal: perform CXL at the slit lamp (in the doctor’s office), not the OR.
Even in extreme cases of keratoconus, corneas with scars or corneas after transplantation, where glasses fail, customized scleral lenses may lead to useful vision.
A transPRK of more than 100 microns on without the use of any mitomycin and in the absence of clinically relevant haze is possible in middle European settings. Now let’s put this into perspective. We have now performed in Switzerland, on Swiss patients, transPRK cases up to minus 12 D in a 6.5 millimeter zone. And that’s more than 140 microns of ablation without mitomycin.
Dr. Emilio Torres-Netto’s moderated poster presentation “Stromal bed smoothness after excimer laser surface ablation as a key element for the expression of inflammatory genes”, which won the Best Poster Prize at Winter ESCRS, in the Refractive Surgery Section.
“CXL for ultra-thin corneas: the sub400 protocol” shows a revolutionary new protocol to treat ultra-thin keratoconic corneas down to 215 µm thickness.
Recognizing the most influential people around the globe in ophthalmology, The Ophthalmologist, an internationally recognized magazine, named Prof. Farhad Hafezi MD, PhD, FARVO of the ELZA Institute, Dietikon, Zurich, Switzerland for the fourth consecutive time to its biennial Power List, listing those 100 people who are the most influential in ophthalmology.
Many women with endometriosis receive “selective tissue estrogenic activity regulator” (STEAR) therapy, but this treatment can cause previously stable keratoconus to start progressing – rapidly
ELZA’s Medical Director, Prof. Farhad Hafezi was an invited international guest speaker at the recent 13th Congrès D’Ophthalmologique Practique (AOPA) at the Hotel Sheraton Alger in Algiers. The congress covered all of ophthalmology, but had a large cornea and refractive sessions, where Prof. Hafezi gave presentations on ELZA’s current research work. His podium presentations reviewed ELZA’s research into refractive surgery, corneal cross-linking and PACK-CXL for the treatment of corneal infection. He also celebrated his birthday while attending the congress!
